Astel­las taps sea­soned CMO amid shift to on­col­o­gy; Doug Man­ion steps in­to a new Are­na fol­low­ing $6.7B buy­out

As Bern­hardt Zei­her re­tires from Astel­las’ chief med­ical of­fi­cer po­si­tion, the se­lec­tion of his suc­ces­sor says a lot about the changes he’s seen at the com­pa­ny over his 12-year tenure.

Tadaa­ki Taniguchi, the new CMO, is a sur­geon in on­col­o­gy by train­ing who’s led de­vel­op­ment for Mer­ck, Bris­tol My­ers Squibb and As­traZeneca in Japan be­fore mov­ing to the US, where he will be based. His most re­cent role at As­traZeneca was SVP, head of on­col­o­gy busi­ness unit Asia strat­e­gy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER